Enfermedad invasora neumocócica en pediatría: ¿qué puede esperarse de la nueva vacuna conjugada neumocócica 13-valente?

PCV13 reduced the incidence of IPD due to vaccine serotypes, especially 19A. The reduction was linked to a reduction in penicillin non-susceptibility. Our findings suggest that the impact of PCV13 on pneumococcal colonization could be exercised on a predominantly susceptible population, probably due to the insufficient time after implementation of PCV7 in Madrid.